Elevance Health Stock Forecast
NYSE: ELVHealth CareMedical SpecialitiesUSD
Market open · Delayed 15 min · as of Oct 9, 12:39 PM ET
ELV analyst consensus
Consensus (22 analysts)
buy
Avg. price target
$451.48+8.81%
- Strong buy 3
- Buy 12
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 22 Wall Street analysts covering Elevance Health (2026-10-07), 15 rate the stock a buy or strong buy, 7 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $451.48, with a high estimate of $492.00 and a low estimate of $393.00. The average target implies upside of 8.8% from the current price of $414.94.
The spread between the highest and lowest targets is 25.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ELV.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 14% |
| Buy | 12 | 55% |
| Hold | 7 | 32% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $393.00 | -5.29% |
| Average target | $451.48 | +8.81% |
| High target | $492.00 | +18.57% |